SWOT Analysis for Ajanta Pharma Ltd. - Strengths

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Rising Net Cash Flow and Cash from Operating activity

Dividend yield greater than sector dividend yield

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Promoter decreasing their shareholding

Promoters increased pledged shares QoQ

PEG greater than Industry PEG

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Increasing Trend in Non-Core Income

High promoter stock pledges

Highest increase in pledges by promoters

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Companies with Upcoming Results

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Companies with high market cap, lower public shareholding

MFs decreased their shareholding last quarter

Rising Delivery Percentage Compared to Prev Day

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks